MedPath
FDA Approval

NUVIGIL

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
STAT Rx USA LLC
DUNS: 786036330
Effective Date
October 8, 2012
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Armodafinil(250 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

PSS World Medical Inc.

101822682

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

STAT Rx USA LLC

STAT Rx USA LLC

PSS World Medical Inc.

786036330

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

NUVIGIL

Product Details

NDC Product Code
16590-394
Application Number
NDA021875
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
September 26, 2012
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
Code: V63XWA605IClass: ACTIMQuantity: 250 mg in 1 1
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
POVIDONEInactive
Code: FZ989GH94EClass: IACT

NUVIGIL

Product Details

NDC Product Code
16590-345
Application Number
NDA021875
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
September 26, 2012
Code: V63XWA605IClass: ACTIMQuantity: 150 mg in 1 1
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
POVIDONEInactive
Code: FZ989GH94EClass: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
© Copyright 2025. All Rights Reserved by MedPath